C8G

C8G encodes the gamma chain of complement component C8, a lipocalin-superfamily protein that forms a disulfide-linked dimer with the alpha chain and participates in assembly of the C5b-9 membrane attack complex (PMID:2613233, PMID:8865989, PMID:7829063). The gene resides on chromosome 9q, distinct from the C8A and C8B genes (PMID:2613233), and unlike other complement proteins its sequence places it in the lipocalin family of small hydrophobic-ligand binders (PMID:8865989, PMID:7829063). Hepatic C8 synthesis is induced by IL-6 as a positive acute-phase response (PMID:7710765), and basal hepatic C8G transcription is driven by the nuclear receptor HNF4α, which binds C8G regulatory regions and transactivates its expression (PMID:39285151). Beyond this classical complement role, astrocyte-expressed C8G functions as a neuroinflammation inhibitor: it binds and antagonizes sphingosine-1-phosphate receptor 2 (S1PR2), suppressing S1P-driven microglial hyperactivation in Alzheimer's disease models (PMID:33382892) and, from perivascular astrocytes, protecting blood-brain barrier integrity by blocking S1PR2-mediated inflammatory activation of endothelial cells (PMID:34149451).

1. 1989 High

   Establishing that C8G is encoded by a gene separate from C8A and C8B clarified the genetic architecture of the trimeric C8 complement protein and the covalent organization of its subunits.

   Evidence Somatic cell hybrid panel analysis with subunit-specific cDNA probes and genomic restriction mapping

   PMID:2613233

   Open questions at the time

   • Does not define the functional contribution of the gamma chain to membrane attack complex activity
   • No structural basis for the alpha-gamma disulfide linkage
2. 1995 Medium

   Classifying the gamma chain as a lipocalin rather than a complement-related protein revealed an unexpected evolutionary origin and predicted a hydrophobic-ligand-binding fold distinct from its complement partners.

   Evidence Sequence homology analysis, chromosomal mapping, and gene-family classification

   PMID:7829063 PMID:8865989

   Open questions at the time

   • No identified physiological hydrophobic ligand
   • Functional significance of the lipocalin fold within C8 unresolved
3. 1995 Medium

   Demonstrating IL-6 induction of C8 subunit biosynthesis placed C8 within the hepatic acute-phase response and identified subunit-specific regulatory modes.

   Evidence Immunoprecipitation/SDS-PAGE of biosynthetically labeled subunits and mRNA analysis in IL-6-treated HepG2 cells

   PMID:7710765

   Open questions at the time

   • Transcription factors mediating IL-6 induction not defined
   • Performed in a single hepatoma cell model
4. 2021 High

   Identifying S1PR2 as a C8G interaction partner revealed a non-complement signaling function in which C8G acts as an endogenous receptor antagonist to restrain neuroinflammation.

   Evidence Recombinant protein gain-of-function and shRNA loss-of-function in acute and chronic Alzheimer's mouse models, with S1PR2 pharmacological manipulation

   PMID:33382892

   Open questions at the time

   • Binding interface and stoichiometry of the C8G–S1PR2 interaction not resolved
   • Relationship between the lipocalin ligand-binding capacity and S1PR2 antagonism unknown
5. 2021 High

   Localizing C8G to perivascular astrocytes and S1PR2 to endothelial cells extended the anti-inflammatory role to blood-brain barrier protection.

   Evidence Immunohistochemistry, intracerebroventricular recombinant protein, shRNA knockdown, in vitro BBB model, and S1PR2 agonists/antagonists

   PMID:34149451

   Open questions at the time

   • Whether astrocyte-derived C8G acts on the same endothelial S1PR2 pool in vivo not directly shown
   • Contribution of complement-derived versus locally secreted C8G unclear
6. 2024 High

   Identifying HNF4α as a transcriptional activator of C8G defined an upstream regulator of its hepatic expression.

   Evidence Liver-specific Hnf4a-null mice, HNF4α knockdown and forced expression in hepatoma/hepatocyte lines, and transactivation assays with binding-site analysis

   PMID:39285151

   Open questions at the time

   • Whether HNF4α regulates astrocyte/brain C8G expression not addressed
   • Interplay with IL-6-driven acute-phase induction not examined
7. 2024 Low

   Correlating serum C8G with urate-lowering therapy linked C8G complement function to gout-associated inflammation, but only as an observational association.

   Evidence Unbiased serum proteomics in two cohorts and proteomics of XOI-treated murine bone marrow macrophages (preprint)

   PMID:38766125

   Open questions at the time

   • No direct mechanistic experiment on C8G itself
   • Causality between C8G levels and gout inflammation not established
   • Preprint, not peer-reviewed

• How the lipocalin ligand-binding pocket of C8G relates mechanistically to both its membrane attack complex role and its S1PR2 antagonism remains unresolved.
• No structure of the C8G–S1PR2 complex
• No identified endogenous hydrophobic ligand
• Unknown whether complement and neuroinflammatory functions share a molecular determinant